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ABSTRACT32
Conjugated linoleic acid (CLA) reduces mammary milk fat synthesis in a dose33
dependant manner. Our objective was to determine the effects of lipid encapsulated34
CLA (LE-CLA) supplementation on milk production, reproductive performance and35
metabolic responses in lactating dairy cows fed a grass-silage based diet. Seventy-two36
Holstein-Friesian cows (32 primiparous and 40 multiparous) were used in a37
completely randomized block design. Cows received either 60 g per day of LE-CLA38
or 60 g per day of calcium salts of palm fatty acids (CSFA; control) from parturition39
until 60 days in milk. The LE-CLA contained a 50:50 mix of cis-9, trans-11 CLA and40
trans-10, cis-12 CLA, resulting in a daily intake of 6 g per day of each isomer. Milk41
production and dry matter intake (DMI) were recorded daily, and blood samples were42
collected 3 times per week. Blood samples were analysed for circulating43
concentrations of glucose, non-esterified fatty acids (NEFA), β-hydroxybutyrate44
(BHBA), insulin and insulin-like growth factor-I (IGF-I). Progesterone was measured45
in blood samples collected after the first postpartum insemination. Ovarian ultrasound46
examinations commenced at 8-10 days postpartum and were carried out 3 times a47
week until first ovulation. The LE-CLA treatment resulted in decreased milk fat48
concentration, with consequent improvements in energy balance and body condition49
score (BCS). The peak concentration of NEFA in blood was reduced by LE-CLA, but50
circulating concentrations of insulin, glucose, IGF-I, BHBA and progesterone were51
not affected. There was no effect of LE-CLA supplementation on the postpartum52
interval to first ovulation. Services per conception tended to be reduced. The53
reduction in milk energy output and improvement in energy status and BCS in LE-54
CLA supplemented cows provides a strong rationale for further studies with greater55
cow numbers to test effects on reproductive performance.56
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59
During early lactation in dairy cattle, the energy required for maintenance and60
milk energy output exceed dietary energy intake (Bell, 1995; Grummer, 1995)61
resulting in negative energy balance (NEB) and consequent body reserve62
mobilisation. Numerous reports have indicated that the duration and extent of NEB63
delay the onset of cyclicity and reduce the likelihood of conception (Beam & Butler,64
1999; Diskin et al., 2003) and also predispose the cow to health problems such as65
fatty liver and ketosis (Drackley, 1999). Efforts to overcome early postpartum NEB66
via dietary means have logically attempted to increase the energy density of the diet67
being fed. However, this approach has been largely unsuccessful. For instance,68
addition of fat to the diet increases the energy density of the diet, but is often69
associated with a modest reduction in DMI such that total energy intake remains70
unaffected (Staples et al., 1998). Alternatively, where additional energy is ingested,71
this may be partitioned to increased milk production such that net energy balance is72
not improved (Santos et al., 2008).73
Conjugated linoleic acids (CLA) are geometric and positional isomers of74
linoleic acid, and are normally produced in the rumen as intermediates in the75
biohydrogenation of linoleic acid to stearic acid (Bauman & Griinari, 2000). Trans-76
10, cis-12 CLA is an isomer of CLA that inhibits milk fat synthesis (Baumgard et al.,77
2000), and has been demonstrated to reduce mammary milk fat synthesis in a dose-78
dependent manner (de Veth et al., 2004). This phenomenon has been observed in79
cows consuming both pasture (Kay et al., 2006; Mackle et al., 2003) and TMR diets80
(Bernal-Santos et al., 2003; Odens et al., 2007) and at varying stages of lactation.81
However, the dose of trans-10, cis-12 CLA necessary to evoke milk fat depression82
(MFD) immediately postpartum (36.9 g/d; Moore et al., 2004) was found to be greater83
than the dose necessary in established lactation (8.8 g/d; Perfield et al., 2002).84
Fat is energetically the most expensive component of milk; daily milk fat85
secretion in early lactation cows represents up to 35% of net energy intake (Bauman86
& Currie, 1980). The milk fat depressing effects of trans-10, cis-12 CLA could87
therefore be used as a management tool to temporarily reduce milk energy output.88
Importantly, milk volume and milk protein concentration are not decreased by CLA89
supplementation, and MFD caused by trans-10, cis-12 CLA is reversible, with milk90
fat content returning to similar levels as control groups at the termination of91
supplementation (Castaneda-Gutierrez et al., 2005).92
Beneficial effects of CLA supplementation on fertility indices have been93
reported, including trends towards decreased interval to first ovulation, elevated94
plasma progesterone during the early luteal phase, increased plasma IGF-I and95
increased pregnancy rate (Bernal-Santos et al., 2003; Castaneda-Gutierrez et al.,96
2007; Castaneda-Gutierrez et al., 2005); this was recently confirmed in a meta-97
analysis of 5 published studies (de Veth et al., 2009). The objective of the present98
study was to determine the effects of feeding a concentrate pellet supplement99
containing lipid encapsulated CLA (LE-CLA) on early lactation milk production,100
bioenergetic and metabolic status, and reproductive indices in dairy cows consuming101
a grass-silage based diet.102
103
MATERIALS AND METHODS104
Animals and treatments105
All experimental procedures involving animals were licensed by the106
Department of Health and Children, Ireland, in accordance with the Cruelty to107
Animals Act (Ireland 1897) and the European Community Directive 86/609/EC. Forty108
multiparous Holstein-Friesian cows were blocked on the basis of expected calving109
date, previous lactation milk yield, and body condition score (BCS), and 32110
primiparous Holstein-Friesian cows were blocked on the basis of expected calving111
date, BCS and bodyweight. Treatments were initiated during a 4-month period. Cows112
were then randomly assigned to receive 80 g per day of LE-CLA (Lutrell Pure; BASF113
SE, Ludwigshafen, Germany) or 60 g per day of calcium salts of palm fatty acids114
(CTL; Megalac; Volac Ltd., Hertfordshire, UK) from parturition until 60 days in milk.115
To facilitate administration of the treatments, the fatty acid supplements were116
incorporated into concentrate pellets such that 2 kg of concentrate contained 60 g of117
LE-CLA or CSFA supplements, and concentrate pellets were fed using automatic118
feeders. A preliminary investigation indicated that the pelleting process resulted in a119
13.4% loss of the trans-10, cis-12 CLA isomer recovered in the concentrate. To120
maintain the minimum targeted dose of 6 g per day of trans-10, cis-12 CLA, the121
incorporation of LE-CLA was increased to 80 g/day. The LE-CLA contained a 50:50122
mix of cis-9, trans-11 CLA and trans-10, cis-12 CLA, resulting in a daily intake of123
6.9 g per day of each isomer after adjusting for losses incurred during pelleting. The124
protection technology for LE-CLA has been previously described (Perfield et al.,125
2004). The cows were housed in a free stall cubicle shed and managed as a single126
group of animals throughout the study period. Three cows were removed from the127
study due to illnesses unrelated to the experimental treatments.128
Individual DMI was measured daily from 3 weeks prior to parturition to 13129
weeks postpartum using the Griffith-Elder Mealmaster feeding system (Griffith Elder130
& Co Ltd, Suffolk, UK). Cows were housed on a straw bed for a variable period of 1131
to 4 days around the time of parturition. Weekly samples of the feeds offered were132
dried and ground, and composited on a monthly basis for nutrient analysis. The dry133
matter, crude protein, NDF, ash and oil content of the feed samples were analysed as134
described by McNamara et al. (2003). The ingredient composition of the prepartum135
and postpartum basal diets and the concentrate supplements are outlined in Table 1.136
Cows were fed daily at 0900 h, and were allowed access to their fat137
supplements from 0900 to 1700. Cows consumed their allocated fat supplements in a138
single meal, and the allotted time allowed ample access time for all cows. Following139
parturition, cows were milked twice daily at 0700 and 1600 h. Milk yield was140
recorded daily at morning and evening milkings using electronic milk meters141
(Dairymaster, Causeway, Co. Kerry, Ireland). Milk composition (fat, protein and142
lactose) was determined on a weekly basis from successive morning and evening milk143
samples by automated infra-red absorption analysis using a Milkoscan 605 (Foss144
Electric, Hillerod, Denmark). Cow body weight (kg) and BCS (Lowman et al., 1976)145
were recorded once per week from parturition until week 13 of lactation.146
Energy balance was estimated as the difference between energy intake and the147
sum of energy requirements for maintenance and milk production, using the French148
net energy system (Jarrige, 1989). This system uses unité fourragère lait (UFL) as the149
unit of net energy, which is equivalent to 1 kg of standard air-dried barley. The150
following equations were used to determine the energy required for maintenance and151
output in milk (O' Mara, 1997);152
energy required for maintenance (UFL/d) = 1.4 + 0.6 BW/100;153
energy requirement for milk (UFL/kg of milk) = 0.0054 FC + 0.0031 PC + LC -0.015;154
where FC = fat concentration (%), PC = protein concentration (%), and LC = lactose155
concentration (%).156
During the period from day 21 before calving to day 28 postpartum, blood157
samples were collected on three days per week (Monday, Wednesday and Friday).158
Thereafter, blood samples were collected every 2 weeks until 10 weeks postpartum. In159
addition, blood samples were collected from each cow 3 times per week for 21 days160
after the first postpartum insemination for progesterone analysis. All blood samples161
were collected from the coccygeal vessels into vacutainers containing lithium heparin162
(Becton Dickinson, Plymouth, United Kingdom) between 0700 and 0800 h after the163
morning milking but before feeding. The samples were immediately centrifuged at164
2000 × g for 15 min. The plasma was decanted into 1.5 mL tubes, sealed with an165
airtight cap, and stored at -20 C until analysis.166
167
Hormone and metabolite analysis168
Blood samples collected that were closest in proximity to days -14, -7, 0, 7, 14, 21,169
28, 42, 56 and 70 relative to parturition were analysed for circulating concentrations170
of glucose, non-esterified fatty acids (NEFA), β-hydroxybutyrate (BHBA), insulin,171
and insulin-like growth factor-I (IGF-I). For example, mean actual sampling day for172
‘Day 7’ samples was day 7, with a range from day 5 to day 9. For ‘Day 14’ samples,173
mean actual sampling day was day 14, with a range from day 12 to 16. All other174
sample days followed a similar pattern. Plasma glucose, NEFA and BHBA175
concentrations were determined by enzymatic colorimetry using an ABX Pentra176
autoanalyzer (ABX Mira, Montpellier, France) and the appropriate enzymatic kits177
(glucose kits supplied by ABX Mira, Montpellier, France; NEFA kits supplied by178
Wako Chemicals GmbH, Neuss, Germany; BHBA kits supplied by Randox179
Laboratories Ltd., Crumlin, Co. Antrim, Northern Ireland). Plasma progesterone and180
insulin concentrations were measured using time-resolved fluoroimmunoassays181
(AutoDELFIA, PerkinElmer Life and Analytical Science, Turku, Finland) with the182
appropriate kits (Unitech BD Ltd., Dublin, Ireland). Circulating concentrations of183
IGF-I were determined by radioimmunoassay following ethanol:acetone:acetic acid184
extraction as previously described (Butler et al., 2004). The inter- and intra-assay185
coefficients of variation for progesterone, insulin and IGF-I were 5.0% and 4.6%,186
4.4% and 5.0%, and 10.9% and 10.9%, respectively. The Revised Quantitative Insulin187
Sensitivity Check Index (RQUICKI) was used to assess insulin sensitivity in lactating188
dairy cows. The index values were calculated using the formula RQUICKI =189
1/[log(glucose) + log(insulin) + log(NEFA)] as described by Holtenius & Holtenius190
(2007).191
192
Reproductive measurements and breeding management193
Ovarian structures were examined by linear array ultrasonography using a 7.5-MHz194
transrectal transducer (Aloka SSD-900; Aloka Ltd., Tokyo, Japan). Ultrasound195
examinations commenced on day 8 to 10 postpartum, and were carried out on 3 days196
per week (Monday, Wednesday and Friday) until first ovulation. Follicles were197
considered to be dominant when a diameter of >10 mm was reached in the absence of198
other large, growing follicles (Savio et al., 1990). Cysts were defined as anovulatory199
follicles >25 mm in diameter that persisted for at least 10 d in the absence of a corpus200
luteum (Garverick, 1997). Initiation of breeding commenced on a calendar mating201
start date, and continued for 15 weeks. Tail paint was used as a heat detection aid, and202
all cows were inseminated using AI following observation of standing estrus, or203
removal of tail paint, or both. Pregnancy diagnoses were carried out at 30 to 36 and 60204
to 66 d post-insemination. Visualization of a fluid-filled horn and a viable embryo205
were used for positive identification of pregnancy.206
207
Milk fatty acid analysis208
Milk samples were collected at 28 DIM (S.D. ± 2.2 days) and analysed for FA209
composition using GLC, as described by Mohammed et al. (2009). Briefly, milk210
lipids were extracted using a chloroform/methanol/water mixture and methylated211
using NaOCH3/methanol. The Fatty Acid Methyl Esters (FAME) were analyzed using212
a Hewlett Packard Model 5890 Series II GLC, and identified by comparison with a213
GLC reference standard (#463) spiked with a mixture of 4 positional conjugated214
linoleic acid (CLA) isomers (#UC-59M), 21:0, 23:0, and 26:0 obtained from Nu-Chek215
Prep Inc, Elysian, Minnesota, USA. Identification of 16:1, 18:1, and 20:1 isomers was216
based on available isomers in the GLC reference standard (#463), comparison with217
published reports, and based on principles of silver-ion separation. Individual FAME218
were reported as a percentage of total FAME.219
220
Statistical analysis221
All statistical analyses were carried out using SAS (SAS System Inc., Cary, NC).222
Daily measurements of milk yield, dry matter intake, and energy balance were223
collapsed into weekly means. A test for normality was performed on all the blood224
analyte data and R-QUICKI values. Each of the variables had a non-normal225
distribution, and were log-transformed prior to analysis to generate a normal226
distribution. Milk production, milk composition, dry matter intake, cow body weight,227
body condition score, energy balance and blood analyte data were analysed using228
mixed models with repeated measures, using the satterthwaite adjustment to calculate229
denominator degrees of freedom. The appropriate covariance structure for each230
repeated measures analysis was identified based on Akaike’s Information Criterion231
(AIC) model fit statistic. Measurements made during the final 3 weeks prepartum232
were included as covariates in the models for glucose, NEFA, BHBA, IGF-I, insulin,233
dry matter intake, cow body weight, body condition score and calculated energy234
balance. Parity and calving day of year were included as adjustment variables in all235
repeated measures models; if non-significant, these variables were removed and the236
models were re-run. Peak NEFA concentration and energy balance nadir after day 1237
of lactation were identified for all cows. Milk fatty acid composition, energy balance238
nadir, timing of energy balance nadir and peak NEFA concentrations were analysed239
using mixed models procedures with treatment as a fixed effect, block as a random240
effect, and calving day of year included as an adjustment variable. All values reported241
are least squares means and SEM. Conception rate data were analysed using the Chi-242
square test, and values reported are treatment means. All other reproductive243
performance data were analysed using mixed models procedures. Data were244
considered significant when P < 0.05, and a trend declared when P < 0.1.245
246
RESULTS247
Milk production, energy balance and BCS248
The milk production results are summarized in Table 2 and Figure 1. Milk fat249
concentration was reduced by LE-CLA (treatment effect: P < 0.001), but there was no250
treatment by time interaction. The greatest reduction in milk fat concentration251
occurred at week 8 postpartum (15.7%) at the end of the supplementation period. Milk252
fat yield was also reduced by up to 15.2% during this period (P = 0.008).253
Supplementation with LE-CLA ceased at 60 DIM, and thereafter milk fat254
concentration in LE-CLA cows began to return toward concentrations similar to the255
control group after week 10 postpartum. Supplementation with LE-CLA had no effect256
on milk yield, the concentration or yield of milk protein, or the concentration or yield257
of milk lactose. Mean daily milk energy output tended (P = 0.06) to be lower for cows258
on the LE-CLA treatment.259
Dry matter intake was not affected by LE-CLA supplementation (17.2 kg/d vs.260
17.3 kg/d CTL and LE-CLA respectively; Figure 2). Mean energy balance was greater261
for the cows on the LE-CLA treatment (P < 0.001; Figure 2). Energy balance nadir262
tended to be less severe in LE-CLA cows (-4.29 UFL/d vs. -3.18 UFL/d CTL and LE-263
CLA respectively, P = 0.09), but the timing of the NEB nadir did not differ (2.2 weeks264
after parturition vs. 1.9 weeks after parturition CTL and LE-CLA respectively).265
Consequently mean postpartum BCS also tended to be greater for LE-CLA cows (P =266
0.09; Figure 2). Body condition score declined in both treatments for the first 3 weeks267
of lactation (BCS change week 1 to week 3 CTL: 3.20 to 3.01, P = 0.01; LE-CLA:268
3.18 to 3.00, P = 0.03). Thereafter LE-CLA cows did not lose any further BCS269
whereas control cows continued to mobilise body reserves until week 5 (BCS change270
week 3 to week 5 CTL: 3.01 to 2.83, P = 0.02; LE-CLA: 3.00 to 3.00, P = 0.99). This271
resulted in a lower mean nadir BCS in CTL cows during weeks 5 to 8 (week 5 to 8272
BCS: 2.96 vs. 2.83; treatment by time, P < 0.05). Cow body weight (BW) was not273
affected by treatment, and there was no treatment by time interaction. Mean BW274
during the treatment period were 555.8 kg and 551.51 kg (CTL and LE-CLA,275
respectively).276
277
Milk fatty acid analysis278
LE-CLA supplementation reduced the proportion of most short and medium chain279
fatty acids in milk fat compared to the CTL animals (Table 4). The proportion of280
C16:0 in milk fat was also decreased by LE-CLA supplementation (P = 0.01). The281
proportion of trans-10, cis-12 CLA in milk fat was increased by LE-CLA282
supplementation (P = 0.01), as were the proportions of other long chain fatty acids283
including C18:0, cis-9 18:1, C18:3 n-3 and C20:0 (all P < 0.03). The proportion of284
cis-9, trans-11 CLA tended to be increased (P = 0.06) by LE-CLA supplementation.285
286
Metabolites and metabolic hormones287
Plasma metabolite data are illustrated in Figure 3. Plasma glucose288
concentrations were not affected by LE-CLA. No differences in mean circulating289
NEFA were detected using repeated measures analysis. Peak circulating290
concentrations of NEFA during the postpartum period were greater in CTL cows291
compared to LE-CLA cows (0.69 ± 0.06 vs. 0.49 ± 0.06 mmol/L, P = 0.004), but the292
mean day when peak circulating NEFA was observed did not differ between293
treatments (6.8 ± 1.1 vs. 5.8 ± 1.1 DIM). Plasma BHBA was not affected by294
treatment. Treatment by time interactions were not observed for any of the blood295
metabolites. Mean circulating concentrations of insulin and the calculated R-QUICKI296
index values were not different between treatments (Figure 4). There were no effects297
of treatment or treatment by time interaction on circulating IGF-I concentrations.298
However, a significant (P < 0.05) effect of parity was detected (128.6, 120.2 and299
108.3 ng/ml for parity 1, 2 and 3 respectively). A treatment by parity interaction (P <300
0.05) was observed, whereby LE-CLA supplementation appeared to increase301
circulating IGF-I in parity 1 cows (135.1 vs. 122.1 ng/ml) and parity 3 cows (117.2302
vs. 99.4 ng/ml), but resulted in reduced circulating IGF-I in parity 2 cows (111.6 vs.303
128.8 ng/ml).304
305
Reproductive performance306
Reproductive performance data are summarized in Table 3. There was no307
difference between treatments in the postpartum interval to onset of cyclicity (21.0 ±308
2.5 vs. 23.3 ± 2.6 days postpartum, CTL and LE-CLA, respectively). Conception rate309
to first or second service were not affected by LE-CLA supplementation, but the310
number of services per conception tended to be reduced (P = 0.07). Calving to service311
interval and calving to conception interval did not differ between the treatments312
(Table 3).313
Circulating concentrations of progesterone during the first 21 days after314
insemination were not affected by LE-CLA supplementation, regardless of whether or315
not a pregnancy was successfully established.316
317
DISCUSSION318
In the present study, LE-CLA supplementation during the first 60 days319
postpartum reduced milk fat concentration, with maximal MFD (15.7%) observed at 8320
weeks after parturition. The energy spared by reducing milk fat synthesis resulted in321
improved calculated energy balance status and BCS. The current study did not have322
had enough animals to allow a robust statistical appraisal of effects of LE-CLA on323
reproductive performance (a Power calculation based on the conception rates to first324
service observed in the current study with α = 0.05 and 1- = 0.9 indicated ~323325
animals per treatment would be required). However the improvements in energy326
status and BCS provide a potential mechanism to improve fertility; this needs to be327
tested in a commercial trial where larger numbers of cows can be enrolled in a study.328
In previous studies that commenced supplementation with CLA before or329
immediately after parturition, MFD did not occur immediately postpartum. Bernal-330
Santos et al. (2003) fed 0 or 8.8 g/d trans-10, cis-12 CLA and Castaneda-Gutierrez et331
al. (2005) fed 0, 8.8 or 18.3 g/d trans-10, cis-12 CLA; they did not observe CLA-332
induced MFD until approximately the third week of lactation. In the current study, we333
observed a significant treatment effect on milk fat concentration, but there was no334
treatment by time interaction, which would suggest that LE-CLA reduced milk fat335
concentration at all timepoints. Moore et al. (2004) suggested that the mammary336
gland is less sensitive to LE-CLA-induced MFD during very early lactation. This was337
also observed by Castaneda-Gutierrez et al. (2005) and they speculated that mammary338
responsiveness and/or sensitivity to trans-10, cis-12 CLA during the early postpartum339
period is altered to support lactation. In the current study, the supplement provided an340
intake of 6.9 g/day of trans-10, cis-12 CLA. This dose is similar to the study of341
Castaneda-Gutierrez et al. (2007), but considerably less than Kay et al. (2006) and342
Odens et al. (2007) who used doses of 20.9 g/day and 29.3 g/day, respectively. It is343
important to note that milk fat is economically important to dairy farmers. Extreme344
MFD may be undesirable, especially in regions where milk is primarily used for345
manufacturing purposes. The amount of LE-CLA supplement fed in the present study346
was chosen to induce sufficient MFD to potentially improve energy status, while not347
markedly decreasing income from milk.348
Supplementation with LE-CLA improved calculated energy balance, and this349
was reflected in improved BCS in the LE-CLA supplemented cows compared to CTL350
animals. To our knowledge, improved BCS in early lactation dairy cows in response351
to CLA supplementation has not previously been reported. The improvement in352
energy balance can be directly attributed to MFD, as DMI and milk yield did not353
differ between CTL and LE-CLA treatment groups. This is consistent with previous354
research that has identified beneficial effects of feeding LE-CLA on energy balance355
indices (Odens et al., 2007; Kay et al., 2007). A recent report on the effects of trans-356
10, cis-12 LE-CLA on adipose tissue supports the effect of LE-CLA on BCS observed357
in the current study. Harvatine et al. (2009) investigated the expression of lipid-358
related genes in adipose tissue during trans-10, cis-12 CLA induced MFD in mid-359
lactation dairy cows (i.e., positive energy balance). Those authors identified a net360
energy excess caused by a decrease in milk fat synthesis, which was accompanied by361
increased expression of genes involved in the uptake, synthesis, desaturation and362
transport of FA in adipose tissue, consistent with enhanced energy partitioning to363
body fat stores during CLA supplementation (Harvatine et al., 2009). In the current364
study, the cows were in early lactation NEB, but it is plausible that energy spared365
through the effects of LE-CLA on milk energy output could affect metabolic366
pathways in adipose tissue to reduce lipid mobilisation in the same manner observed367
by Harvatine et al. (2009).368
Reduced severity of NEB should reduce the demand to mobilise adipose tissue369
reserves. We did not detect an effect of CLA on mean circulating NEFA370
concentrations during the supplementation period, but peak circulating NEFA371
concentrations were lower in the CLA supplemented cows compared to the CTL372
cows. The literature is inconsistent with regard to the effect of LE-CLA on circulating373
NEFA concentrations, with some reports identifying a reduction in NEFA in LE-CLA374
supplemented cows (Odens et al., 2007) while others reported no effect (Kay et al.,375
2007; Castaneda-Gutierrez et al., 2005). Collectively, the results of the present and376
earlier studies indicate that (i) CLA acts to lower NEFA only if supplementation is377
initiated at or before parturition; (ii) reductions in NEFA are not detectable if378
circulating NEFA is already low at the start of the study (mid- to late-lactation cows379
in positive energy balance); and (iii) ability to detect an effect of CLA treatment on380
NEFA with a small number of cows per treatment is hindered by the high variability381
that is typically observed in circulating NEFA concentrations during the transition382
period. Lower circulating NEFA during the transition period may result in reduced383
liver uptake of NEFA and subsequent esterification to triglycerides, resulting in a384
beneficial effect on liver health status (Drackley, 1999).385
We observed no differences in plasma glucose concentrations for LE-CLA386
supplemented cows compared with CTL cows. The literature is inconsistent on the387
effect of CLA on plasma glucose in early lactation dairy cows. Odens et al. (2007)388
observed greater plasma glucose in cows supplemented with a high dose of CLA, but389
other studies have failed to detect a similar effect (Bernal-Santos et al., 2003; Kay et390
al., 2006; Castaneda-Gutierrez et al., 2005). Odens et al. (2007) attributed the greater391
circulating glucose concentrations to a possible decrease in peripheral tissue insulin392
sensitivity. However, studies where an insulin tolerance test was used to measure393
insulin sensitivity in cows either abomasally infused with CLA (Baumgard et al.,394
2002a) or fed LE-CLA (de Veth et al., 2006) reported no difference in the fractional395
rate of change in circulating glucose following insulin administration. Similarly, LE-396
CLA supplementation did not affect the R-QUICKI index values in the present study,397
again suggesting insulin sensitivity was not affected. It is possible that the effects of398
CLA on peripheral tissue insulin responsiveness are subtle, and cannot be detected399
using techniques such as the insulin tolerance test or the R-QUICKI index in lactating400
dairy cows.401
The current study was not adequately powered to detect effects on402
reproduction related variables. Accordingly, we did not observe any effect on the403
majority of the fertility measurements, with the exception of a trend for a reduced404
number of services per conception (for all cows, pregnant and non-pregnant) in LE-405
CLA supplemented cows. A limited number of published reports, all with low406
numbers of cows per treatment, have indicated statistical trends for beneficial effects407
of CLA on fertility indices (Castaneda-Gutierrez et al., 2005, n = 18/treatment;408
Bernal-Santos et al., 2003, n = 15/treatment; Castaneda-Gutierrez et al., 2007, n =409
15/treatment). Beneficial effects included trends for reduced postpartum interval to410
first ovulation, numerical improvements in conception rate, and reduced number of411
services per conception. The data from these three studies were combined with data412
from Mann et al. (2007) and de Veth et al. (2005) in a recent meta-analysis (de Veth413
et al., 2009) which indicated that the optimal dose for advancing the postpartum onset414
of cyclicity was 8 g/d trans-10, cis-12 CLA; interval to first postpartum ovulation was415
reduced by 8 days in cows fed this dose (de Veth et al., 2009). The optimal dose for416
improving conception was 10 g/d trans-10, cis-12 CLA; this dose increased the417
probability of cows becoming pregnant (72% vs. 91%) and reduced the time to418
conception (143 DIM vs. 105 DIM) compared to cows receiving no supplement (de419
Veth et al., 2009). In the current study, we did not observe an effect of LE-CLA420
feeding on postpartum onset of cyclicity; resumption of luteal activity occurred early421
postpartum in both the LE-CLA and CTL treatment groups. The effects of LE-CLA422
on conception related variables in the present study are generally in agreement with423
previous reports (Bernal-Santos et al., 2003; Castaneda-Gutierrez et al., 2007;424
Castaneda-Gutierrez et al., 2005) and the recent meta-analysis (de Veth et al., 2009).425
Insulin-like Growth Factor-I is a polypeptide hormone, the concentration of426
which in circulation is correlated with nutritional status (McGuire et al., 1995) and427
reproductive performance in dairy cattle (Taylor et al., 2004). Castaneda-Gutierrez et428
al. (2007) previously reported greater circulating IGF-I in LE-CLA supplemented429
cows compared to control cows, despite not detecting an effect on energy balance. In430
the current study, the effect of LE-CLA on circulating IGF-I concentrations appeared431
to differ by parity, but similar treatment by parity interactions were not observed in432
the analysis of energy balance and BCS. Further work is necessary to determine if the433
effect of CLA on circulating IGF-I truly differs by parity.434
Progesterone is a steroid hormone that is critical for successful establishment435
of pregnancy. In a synchronized cycle, Castaneda-Gutierrez et al. (2007) observed436
greater progesterone concentrations during the luteal phase in LE-CLA supplemented437
cows. In the current study, progesterone was measured for 21 days after insemination,438
but LE-CLA did not affect concentrations in cows that were subsequently diagnosed439
either pregnant or non-pregnant. The differences between the results of the current440
study and those of Castaneda-Gutierrez et al. (2007) in IGF-I and progesterone441
hormone profiles warrant further study.442
The milk fatty acid results indicated that approximately 0.18 g of trans-10, cis-443
12 LE-CLA escaped biohydrogenation and was available for intestinal absorption,444
representing a transfer efficiency of 2.7%. Three other studies have fed LE-CLA445
supplements, reporting transfer efficiencies of 2.6 % (de Veth et al., 2006), 4.8 %446
(Moallem et al., 2010) and 7.9 % (Perfield et al., 2004). The variation in transfer447
efficiencies between studies may partly reflect differences in the technology used to448
protect CLA in the different studies. The transfer efficiency in the present study was449
achieved despite pelleting the LE-CLA supplement, which could potentially lead to450
degradation of the lipid encapsulation protection due to heating during the pelleting451
process. This may enhance the potential for practical application of the LE-CLA452
supplement used in the current study. Though it is likely that the pelleting process had453
some detrimental effect on rumen protection, under the conditions that LE-CLA was454
pelleted in this study, the supplement remained efficacious at reducing milk fat455
content.456
The changes in milk fat composition in response to LE-CLA supplementation457
in the present study – i.e., decreasing proportions of short and medium chain fatty458
acids and increasing proportions of long chain fatty acids – are consistent with other459
reports (Mackle et al., 2003; Perfield et al., 2002; Castaneda-Gutierrez et al., 2005).460
Collectively, these studies indicate that the reduction in milk fat synthesis during CLA461
supplementation is due to reductions in both the uptake of preformed fatty acids and,462
to a greater extent, de novo mammary synthesis of short chain fatty acids. Baumgard463
et al. (2002b) demonstrated that trans-10, cis-12 CLA decreases milk fat synthesis464
through a reduction in mRNA expression for key enzymes involved in fat synthesis in465
the mammary gland, as well as enzymes involved in the uptake and transport of466
circulating fatty acids.467
468
CONCLUSIONS469
Supplementation with LE-CLA induced MFD in early lactation dairy cows, with no470
effect on milk yield, or the yield of milk protein or lactose. The reduction in milk fat471
output resulted in greater net energy balance in LE-CLA supplemented cows, and this472
was reflected in improved BCS. The number of services per conception tended to be473
lower in LE-CLA supplemented cows, although no other reproduction variables were474
changed. The current study goes beyond previous work by demonstrating effects on475
energy balance and BCS by feeding a small amount of supplemental LE-CLA in476
pelleted form. Because of the well established relationship between energy balance477
and reproduction in lactating dairy cows, and a recent meta-analysis indicating CLA478
can benefit reproduction, further work with a larger number of animals is necessary to479
fully determine the effects of LE-CLA on cow fertility.480
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619
Table 1. Ingredient and nutrient composition of the feeds offered620
TMR ingredients (% of DM) Prepartum Postpartum
Grass silage 100 50
Soya hulls 25
TMR premix1 25
Nutrient composition of TMR
DM (g/kg) 234 364
Net energy (UFL/kg DM)2 0.75 0.91
Ash (g/kg DM) 84 74
Crude protein (g/kg DM) 157 175
NDF (g/kg DM) 536 462
Concentrate supplement (% as fed) CTL LE-CLA
Barley 20.0 20.0
Citrus pulp 26.1 26.1
Maize gluten feed 26.5 26.5
Soyabean meal 19.0 19.0
CSFA 4.4 -
LE-CLA - 4.4
Vitamins and minerals3 4.0 4.0
Nutrient composition of concentrate
DM (g/kg) 879 879
Net energy (UFL/kg DM) 1.15 1.15
Ash (g/kg DM) 109 97
Crude protein (g/kg DM) 184 196
NDF (g/kg DM) 205 218
Oil (acid hydrolysis) % 35 54
1Ingredient composition: 60% rolled barley, 36% soyabean meal, 4% vitamins and minerals3621
2UFL = unité fourragère lait; unit of net energy, equivalent to 1 kg of standard air-dried barley622
3Vitamin and mineral mix: 15 g/kg dicalcium phosphate, 8 g/kg limestone flour, 5 g/kg salt, 2.5 g/kg623
calcined magnesite, 80 mg manganous oxide, 200 mg copper sulphate, 125 mg zinc oxide, 18 mg624
potassium iodate, 20 mg sodium selenite (4.6%), 10 mg cobalt sulphate, 8 MIU/t vitamin A, 2 MIU/t625
vitamin D3, 15,000 IU/t vitamin E.626
627
Table 2. Least squares means for milk yield and milk composition during the628
treatment period629
Treatment1 P-value4
CTL LE-CLA S.E.M Trt Trt × Time
Milk yield (kg/day) 26.5 26.5 0.9 0.9 0.8
Milk fat
% 4.26 3.78 0.11 <0.001 0.4
kg/day 1.08 0.98 0.04 0.008 0.5
Milk protein
% 3.12 3.07 0.05 0.4 0.14
kg/day 0.81 0.78 0.03 0.15 0.7
Milk lactose
% 4.63 4.62 0.03 0.7 0.6
kg/day 1.23 1.22 0.04 0.8 0.8
Milk energy (UFL/day) 2 11.4 10.7 0.4 0.06 0.7
Milk energy (Mcal/day) 3 19.4 18.3 0.7 0.06 0.7
1 CTL = Control; LE-CLA = Lipid Encapsulated Conjugated Linoleic Acid630
2UFL = unité fourragère lait; unit of net energy, equivalent to 1 kg of standard air-dried barley631
3Milk energy (Mcal/day) = ((0.0929*Fat %) + (0.0563*Protein %) + (0.0395*Lactose %)) * Milk yield632
4The effect of time was significant (P<0.05) for all variables633
Table 3. Reproductive performance of cows on the CTL and LE-CLA supplements634
Treatment1
CTL LE-CLA P-value
Interval to 1st ovulation (days) 21.0 (± 1.6) 23.3 (± 1.7) 0.6
Dom. foll. diameter at 1st ovulation2 (mm) 15.4 (± 0.8) 14.8 (± 0.8) 0.5
Wave number at 1st ovulation3 1.48 1.52 0.9
Conception rate to first service (%) 38.9 (14/36) 51.5 (17/33) 0.3
Conception rate to second service (%) 66.7 (14/21) 76.9 (10/13) 0.7
Services/conception for pregnant cows (n) 1.63 (± 0.15) 1.48 (± 0.14) 0.3
Services/conception for all cows (n) 2.00 (± 0.15) 1.72 (± 0.16) 0.07
Calving to service interval (days) 81.1 (± 6.1) 83.2 (± 6.5) 0.7
Calving to conception interval (days) 111.0 (± 8.8) 109.1 (± 8.6) 0.8
1 CTL = Control; LE-CLA = Lipid Encapsulated Conjugated Linoleic Acid635
2The maximum diameter of the first postpartum ovulatory dominant follicle.636
3The follicle wave when the first postpartum ovulation occurred.637
Table 4. Milk fatty acid composition (g/100g total fatty acids) of cows on the CTL638
and LE-CLA supplements at week 4 of lactation639
1 CTL = Control; LE-CLA = Lipid Encapsulated Conjugated Linoleic Acid640
641
Treatment1
CTL LE-CLA S.E.M P-value
4:0 3.36 3.58 0.067 0.03
6:0 1.93 1.80 0.035 0.03
8:0 1.11 0.98 0.029 <0.01
10:0 2.40 2.04 0.087 0.01
10:1 0.28 0.22 0.013 <0.01
11:0 0.06 0.04 0.005 0.02
12:0 2.75 2.28 0.103 <0.01
12:1 0.07 0.06 0.008 0.69
13:0 0.10 0.09 0.005 0.23
14:0 9.95 8.98 0.235 0.01
14:1 1.09 0.90 0.037 <0.01
15:0 1.15 1.08 0.027 0.07
16:0 30.90 28.62 0.650 0.01
cis-9 16:1 1.42 1.43 0.062 0.98
17:0 0.71 0.77 0.015 0.02
17:1 0.35 0.39 0.012 0.01
18:0 8.44 9.68 0.352 0.02
trans-11 18:1 1.40 1.49 0.072 0.37
cis-9 18:1 17.59 20.22 0.697 0.01
cis-11 18:1 0.43 0.47 0.030 0.44
18:2n-6 1.64 1.69 0.051 0.50
18:3n-3 0.51 0.56 0.017 0.02
20:0 0.12 0.15 0.006 <0.01
cis-9, trans-11 CLA 0.51 0.58 0.026 0.06
trans-10, cis-12 CLA 0.01 0.02 0.003 0.01
20:1 0.09 0.10 0.005 0.25
20:4n-6 0.10 0.11 0.004 0.25
All <C:16 23.09 20.94 0.475 <0.01
All C:16 32.08 29.55 0.652 <0.01
All >C16 33.37 37.67 1.040 <0.01
Figure 1. Temporal changes in milk yield, milk fat concentration and milk fat yield642
during the treatment and post-treatment periods. The treatment period lasted from643
parturition to 60 DIM, and cows were fed either 60 g/day of calcium salts of fatty644
acids (CTL) or 80 g/day of LE-CLA (LE-CLA). All values are LSM.645
646
Figure 2. Effect of treatment on dry matter intake, energy balance and body condition647
loss. The treatment period lasted from parturition to 60 DIM, and cows were fed648
either 60 g/day of calcium salts of fatty acids (CTL) or 80 g/day of lipid-encapsulated649
LE-CLA (LE-CLA). All values are LSM.650
651
Figure 3. Temporal changes in circulating glucose, NEFA and BHBA in cows652
supplemented with CTL and LE-CLA supplements. The treatment period lasted from653
parturition to 60 DIM (depicted by the solid black bar), and cows were fed either 60654
g/day of calcium salts of fatty acids (CTL) or 80 g/day of LE-CLA (LE-CLA).655
Glucose, NEFA and BHBA values were not normally distributed and were log-656
transformed prior to analysis to generate a normal distribution.657
Figure 4. Plasma insulin concentrations and R-QUICKI values in CTL and LE-CLA658
supplemented cows. The treatment period lasted from parturition to 60 DIM (depicted659
by the solid black bar), and cows were fed either 60 g/day of calcium salts of fatty660
acids (CTL) or 80 g/day of LE-CLA (LE-CLA). Upper panel: Insulin values were log-661
transformed prior to analysis to generate a normal distribution. Lower panel: R-662
QUICKI values were generated by taking both the logarithm and reciprocal of663
glucose×insulin×NEFA. The R-QUICKI values generated were not normally664
distributed, and were log-transformed prior to analysis.665
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